RS Crum Inc. Sells 127 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

RS Crum Inc. lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.3% during the third quarter, Holdings Channel.com reports. The fund owned 9,656 shares of the financial services provider’s stock after selling 127 shares during the period. RS Crum Inc.’s holdings in iShares Biotechnology ETF were worth $1,406,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Blue Fin Capital Inc. lifted its stake in iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak lifted its stake in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the last quarter. SPC Financial Inc. grew its holdings in iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares during the period. Werba Rubin Papier Wealth Management increased its position in iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the last quarter. Finally, Main Street Financial Solutions LLC raised its stake in iShares Biotechnology ETF by 1.0% in the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after buying an additional 82 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.2 %

Shares of NASDAQ IBB opened at $140.23 on Wednesday. iShares Biotechnology ETF has a 12 month low of $117.28 and a 12 month high of $150.57. The stock has a 50 day moving average of $143.27 and a 200-day moving average of $141.92.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.